News | June 12, 2008

Siemens SPECT Makes its First U.S. Appearance

June 13, 2008 - Siemens will highlight the Symbia SPECT and SPECT/CT family of imagers, and for the first time in the U.S., the Symbia E SPECT, addressing the needs of the cost-conscious consumer by redefining the quality of cost-efficient molecular imaging.

The newest addition to the Symbia family of SPECT and SPECT-CT imaging systems, Symbia E works to provide users with a high-quality SPECT imager that can lead to improved clinical confidence, reliability and versatility.

Symbia E is reportedly primed to be the newest general imaging SPECT and cardiac SPECT workhorse for customers who require a quick return on their investment; especially important in the post-DRA environment.

According to Siemens, a new generation of HD detectors is the key innovation leading to best-in-class performance and reliability. Using these detectors, where Siemens achieved an 85 percent reduction in wiring and a 75 percent reduction in components, the overall reliability of the product is significantly increased. Symbia E is reportedly primed to be the newest general imaging SPECT and cardiac SPECT workhorse for customers who require a quick return on their investment; especially important in the post-DRA environment.

For more information: www.usa.siemens.com/medical

Related Content

Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
Cardiac MRI being performed at the DeBakey Heart Hospital.

Cardiac MRI being performed at the DeBakey Heart Hospital.

Feature | Cardiac Imaging | May 03, 2018 | By Jeff Zagoudis
Magnetic resonance imaging (MRI) for cardiac assessment provides a radiation-free alternative to other commonly used...
The Chalk River nuclear reactor license has been renewed, but will be decommissioned by 2028.

The Chalk River nuclear isotope reactor license has been renewed, but will be decommissioned by 2028. The reactor supplies about 50 percent of the world's supply of Tc99m.

Feature | Nuclear Imaging | April 02, 2018 | Dave Fornell
April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear Lab
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
GE Healthcare SPECT/CT and PET/CT Systems Enhance Personalized Patient Care
News | Nuclear Imaging | June 10, 2017
GE Healthcare showcased positron emission tomography (PET) and single photon emission computed tomography/computed...
advanced visualization
News | Molecular Imaging | June 09, 2017
The Food and Drug Administration (FDA) has cleared syngo.via VB20 for Molecular Imaging (MI) from Siemens Healthineers...
Siemens Healthineers Debuts Symbia Intevo Bold SPECT/CT
News | SPECT-CT | June 08, 2017
Siemens Healthineers debuts Symbia Intevo Bold at the 2017 annual meeting of the Society of Nuclear Medicine &...